Clinical experience with filler complications.
Cox
Sue Ellen
SE
Department of Dermatology, University of North Carolina at Chapel Hill, North Carolina, USA. sec@aesthetic-solutions.com
D000153:Acne Keloid / Q000601:surgery / Q000628:therapy*; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001672:Biocompatible Materials / Q000008:administration & dosage / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004438:Ecchymosis / Q000139:chemically induced; D004890:Erythema / Q000139:chemically induced; D005145:Face; D005260:Female; D005549:Foreign-Body Reaction / Q000139:chemically induced* / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D019344:Lactic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D011091:Polyesters; D011108:Polymers / Q000008:administration & dosage / Q000009:adverse effects*; D012060:Rejuvenation; D015595:Skin Aging; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D001672:Biocompatible Materials; D003879:Dermatologic Agents; D011091:Polyesters; D011108:Polymers; D019344:Lactic Acid; C033616:poly(lactide); D006820:Hyaluronic Acid; D006821:Hyaluronoglucosaminidase